CHU Gabriel Montpied
CHU Gabriel Montpied
Clermont-Ferrand, France6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation | Symptomatic Severe Aortic Stenosis | Active, not recruiting | Not applicable | 2026-04-13 | NCT04788888 | |
| Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus | Embolism, Embolism and Thrombosis, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, acute coronary syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, heart failure, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-02-17 | NCT05825573 | |
| Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura | brain disorder, central nervous system disorder, epilepsy, headache disorder, hypnic headache, migraine disorder, migraine with aura, nervous system disorder | Recruiting | Phase 2 | 2025-12-04 | NCT04063540 | |
| Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 | 2025-11-18 | NCT05781308 | |
| Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 3 | 2025-09-12 | NCT03127267 | |
| French Observatory of ElectroConvulsive Therapy (ECT) | psychiatric disorder | Recruiting | Not stated | 2024-08-20 | NCT04477434 |